• About us
• Contact

Advertisement

Organisation › Details

Lonza (Group)

Lonza is the preferred global partner to the pharmaceutical, biotech and nutrition markets. We work to prevent illness and enable a healthier world by supporting our customers to deliver new and innovative medicines that help treat a wide range of diseases. We achieve this by combining technological insight with world-class manufacturing, scientific expertise and process excellence. These enable our customers to commercialize their discoveries and innovations in the healthcare sector. Founded in 1897 in the Swiss Alps, today Lonza operates acrossfive continents. With approximately 14,000 full-time employees, we are built from high-performing teams and of individual talent who make a meaningful difference to our own business, as well as to the communities in which we operate. The company generated sales of CHF 4.5 billion in 2020 with a CORE EBITDA of CHF 1.4 billion. Find out more at www.lonza.com *

 

	Start	1999-11-01 splitoff
	Industry	contract manufacturing (biologicals)
	Person	Ruffieux, Pierre-Alain (Lonza 202011– CEO before Roche + Novartis + Serono)
	Person 2	Savitzky, Rodolfo (Lonza 201801 CFO)
	Region	Basel BS
	Country	Switzerland
	Street	38 Münchensteiner Str.
	City	4002 Basel BS
	Tel	+41-61-316-8111
		Address record changed: 2024-01-05
Basic data	Employees	H: 10,001 to 50,00 (2022-03-23)
	Currency	CHF
	Annual sales	6,717,000,000 (sales, consolidated (2023) 2023-12-31)
	Profit	655,000,000 (2023-12-31)
	Cash	1,468,000,000 (2023-12-31)
		* Document for »About Section«: Lonza Group AG. (5/6/21). "Press Release: Lonza Announces Expansion Plans for Next-Generation Mammalian Manufacturing Facilities in Visp (CH) and Portsmouth (US)". Basel.
		Record changed: 2024-12-29

Advertisement

More documents for Lonza (Group)

• [1] Lonza Group AG. (4/2/24). "Press Release: Wolfgang Wienand, Currently CEO of Swiss CDMO Siegfried Holding AG, Will Become Chief Executive Officer of Lonza in the Summer of 2024". Basel....
• [2] Lonza Group AG. (3/20/24). "Press Release: Lonza Signs Agreement to Acquire Large-scale Biologics Site in Vacaville (US) from Roche". Basel....
• [3] Cellbox Solutions GmbH. (11/1/23). "Press Release: Dr. Hartmut Tintrup Joins Cellbox Solutions GmbH as new CEO". Cologne....
• [4] Lonza Group AG. (9/18/23). "Press Release: Board Announcement. CEO Pierre-Alain Ruffieux to Leave Lonza – Albert M. Baehny to Step in as CEO ad interim". Basel....
• [5] PolyPeptide Group AG. (8/15/23). "Press Release: Transformational Progress Taking Shape, Profitability Impacted by Rapid Expansion – Appointment of Marc Augustin as New CFO". Baar....
• [6] Lonza Group Ltd.. (6/1/23). "Press Release: Lonza to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering". Basel & Amsterdam....
• [7] Emergence Therapeutics AG. (9/6/22). "Press Release: Emergence Therapeutics Licenses Synaffix ADC Technology Platform in $360M Deal". Amsterdam & Duisburg....
• [8] Rentschler Biopharma SE. (8/18/22). "Press Release: Rentschler Biopharma Appoints Mark Caswell as Vice President, Site Head for US Facility". Laupheim & Milford, MA....
• [9] Merck KGaA. (4/5/22). "Press Release: Merck Advances BioProcessing Capabilities with Acquisition of MAST Platform from Lonza, a Leading Automated Bioreactor Sampling System". Darmstadt....
• [10] Lonza Group Ltd.. (3/23/22). "Press Release: Christian Seufert Appointed as President of Capsules and Health Ingredients Division". Basel....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.